Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 5 Finished
-
Gut-liver crosstalk by FGF15/19 in regulating xenobiotic nuclear receptor activation
National Institute of General Medical Sciences
7/1/20 → 4/30/22
Project: Research project
-
Differential roles of FXR and FGF15 in liver fibrosis development
National Institute of Environmental Health Sciences
4/1/18 → 3/31/21
Project: Research project
-
Gut bile acids, Fxr, & Fgf15 in total parenteral nutrition-associated cholestasis
National Institute of General Medical Sciences
7/5/13 → 5/31/18
Project: Research project
-
FXR, nuclear receptors, and transcriptional regulation of liver homeostasis
9/26/11 → 8/31/13
Project: Research project
-
Tissue specific mechanism of FXR in suppressing bile-acid synthesis
National Institute of Diabetes and Digestive and Kidney Diseases
6/10/08 → 5/31/13
Project: Research project
-
FXR Friend-ChIPs in the Enterohepatic System
Meadows, V., Yang, Z., Basaly, V. & Guo, G. L., 2023, (Accepted/In press) In: Seminars in Liver Disease.Research output: Contribution to journal › Article › peer-review
Open Access -
Gut-specific inhibition of PPARα as a novel approach of NAFLD treatment
Zhang, L. & Guo, G. L., Jan 2023, In: Hepatology. 77, 1, p. 15-17 3 p.Research output: Contribution to journal › Editorial › peer-review
2 Scopus citations -
In vivo mouse models to study bile acid synthesis and signaling
Bhattacharya, A., Taylor, R. E. & Guo, G. L., 2023, (Accepted/In press) In: Hepatobiliary and Pancreatic Diseases International.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Myclobutanil-mediated alteration of liver-gut FXR signaling in mice
Taylor, R., Armstrong, L., Bhattacharya, A., Henry, Z., Brinker, A., Buckley, B., Kong, B. & Guo, G., Feb 1 2023, In: Toxicological Sciences. 191, 2, p. 387-399 13 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation
Jiang, M., Li, F., Liu, Y., Gu, Z., Zhang, L., Lee, J., He, L., Vatsalya, V., Zhang, H. G., Deng, Z., Zhang, X., Chen, S. Y., Guo, G. L., Barve, S., Mcclain, C. J. & Feng, W., Apr 2023, In: Hepatology. 77, 4, p. 1164-1180 17 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations